Podiatrists in Marysville, WA Accepting Medicare
4 Podiatrists found. Showing 1 - 4
 Dr. Michael A Thomas, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2901 174th St Ne, Marysville, WA 98271 Phone: 360-454-5407 Fax: 360-454-1968 |
 Marysville Foot & Ankle Clinic Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9516 State Ave, Suite D, Marysville, WA 98270 Phone: 360-653-3354 Fax: 360-658-1534 |
 Shannon Curran, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 8923 Soper Hill Rd, Marysville, WA 98270 Phone: 425-397-1700 |
Megan Leigh Wilder, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2901 174th St Ne, Marysville, WA 98271 Phone: 360-454-1907 |
News Archive
FibroGen announces study results of recombinant human type III collagen in corneal damage
FibroGen, Inc., today announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company's proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss.
NeoGenomics launches FISH assay for surveillance of patients with Barrett's Esophagus
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today it has validated and launched a laboratory developed Fluorescent in Situ Hybridization assay for the surveillance of patients with Barrett's Esophagus.
Key part of MRSA vaccine puzzle unearthed
Immunologists from Trinity College Dublin have unearthed a key piece of the MRSA vaccine puzzle by identifying specific ‘helper' cells whose role in the immune response is critical in affecting infection outcomes.
Black people are more likely to survive a stroke than white people
The risk of stroke and death from stroke are generally higher in black people than whites in the United Kingdom and the United States. In south London, where this study took place, the average age of people with stroke is 10 years lower than in the whole population.
Scientists develop first dual-action drug against melanoma skin cancer cells
Scientists are reporting development and successful lab tests on the first potential drug to pack a lethal one-two punch against melanoma skin cancer cells. Hit number one destroys cells in the main tumor, and the second hit blocks the spread of the cancer to other sites in the body, according to their report in the journal ACS Chemical Biology.
› Verified 5 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Occupational Therapists
Optometrists
Podiatrists
Audiologists